Sanjay Rajanikant Mehta
Direttore/Membro del Consiglio presso Zuventus Healthcare Ltd.
Patrimonio netto: 158 $ in data 30/09/2021
Posizioni attive di Sanjay Rajanikant Mehta
Società | Posizione | Inizio | Fine |
---|---|---|---|
Zuventus Healthcare Ltd.
Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Direttore/Membro del Consiglio | 11/05/2011 | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01/04/1989 | - |
Storia della carriera di Sanjay Rajanikant Mehta
Formazione di Sanjay Rajanikant Mehta
University of Pune | Undergraduate Degree |
Statistiche
Distribuzione geografica
India | 4 |
Posizioni
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Zuventus Healthcare Ltd.
Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |